Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors

Dartevelle, Philippe; Chapelier, Alain; Pastorino, Ugo; Corbi, Pierre; Lenot, Bernard; Cerrina, Jacques; Bavoux, E; Verley, J. M.; Neveux, Jean-Yves; Boyd, Arthur D.

doi:10.1016/s0022-5223(19)36558-4

Cited by 144 publications

(57 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The polytetrafluoroethylene tube graft has currently been commonly used as an extracardiac conduit for EC-TCPC because of its excellent antithrombogenicity and antipannus formation. 13,14 As we demonstrated in this study, the intraluminal diameter of the grafts remained unchanged in spite of the somatic growth of the patients. We believed that permanent use of warfarin, maintaining the INR between 1.5 and 2.0, in addition to the usage of polytetrafluoroethylene tube graft might contribute to this favorable result.…”

Section: Discussionsupporting

confidence: 60%

The Somatic Growth of Autologous Vessels in Venous Pathway After Extracardiac Total Cavopulmonary Connection

Iwaki

Masuda

Shiokawa

et al. 2008

Journal of Cardiac Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 60%

The Somatic Growth of Autologous Vessels in Venous Pathway After Extracardiac Total Cavopulmonary Connection

Iwaki

Masuda

Shiokawa

et al. 2008

Journal of Cardiac Surgery

View full text Add to dashboard Cite

show abstract

“…Regarding the treatment, both conditions may be approached by either conventional surgery or endovascular technique. In cases of malignant origin, endovascular recanalization is clearly the treatment of choice [5][6][7][8][9] , and surgical repair should be reserved for resectable tumors [10][11][12][13] . In cases of superior vena casa syndrome of benign cause, the open surgical approach remains the treatment of choice [14][15][16][17] , although some authors sustain their preference for the endovascular technique, regardless of the costs of additional interventions and the need for longer follow-up [18][19][20] .…”

Section: Discussionmentioning

confidence: 99%

Tratamento convencional e endovascular para rara associação de doenças: síndrome de veia cava superior e aneurisma aorto-ilíaco - controle após 12 meses

Solano¹,

Melo²,

Arantes³

et al. 2011

J. vasc. bras.

View full text Add to dashboard Cite

A associação entre a síndrome de veia cava superior e uma dilatação aneurismática das artérias aorta e ilíacas não é comum. A abordagem de cada uma destas patologias pode ser efetuada através do modo convencional, com cirurgia aberta ou pela técnica endovascular. Neste trabalho, relatamos as duas modalidades de intervenção cirúrgica executadas e discutimos suas indicações e os resultados deste caso em particular.

show abstract

“…Among the synthetic materials employed for graft reconstruction of the SVC (Dacron, PTFE, Gore-tex), the PTFE is the option of choice. It is the synthetic material showing the highest patency rate at long term and, shortly after its implantation, it becomes re-epithelialized with autogenous epithelial cells in humans (11,19). PTFE grafts (that are usually reinforced with external rings) have low risk of infection, less platelet deposition, and less thrombogenicity of the flow surface if compared with Dacron grafts.…”

Section: Materials For Vascular Reconstructionmentioning

confidence: 99%

Salvage resection of advanced mediastinal tumors

et al. 2019

View full text Add to dashboard Cite

The surgical treatment of locally advanced mediastinal tumors invading the great vessels and other nearby structures still represent a tricky question, principally due to the technical complexity of the resective phase, the contingent need to carry out viable vascular reconstructions and, therefore, the proper management of pathophysiologic issues. Published large-number series providing oncologic outcomes of patients who have undergone extended radical surgery for invasive mediastinal masses are just a few. Furthermore, the wide variety of different histologies included in some of these studies, as well as the heterogeneity of chemo and radiation therapies employed, did not allow for the development of clear oncologic guidelines. Usually in the past, surgical resections of large masses along with the neighbouring structures were not offered to patients because of related morbidity and mortality and limited information available on the prognostic advantage for long term. However, in the last decades, advances in surgical technique and perioperative management, as well as increased oncologic experience in this field, have allowed radical exeresis in selected patients with invasive tumors requiring resections extended to the surrounding structures and complex vascular reconstructions. Such aggressive surgical treatment has been proposed in association or not with adjuvant chemo-or radiotherapy regimens, achieving encouraging oncologic results with limited morbidity and mortality in experienced institutions. Congestive heart failure or impending cardiovascular collapse due to the compression by the large mass are the most frequent immediately lifethreatening problems that some of these patients can experience. In this setting, medical palliation is usually ineffective and an aggressive salvage surgical treatment may remain the only therapeutic option.

show abstract

Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors

Cited by 144 publications

References 18 publications

The Somatic Growth of Autologous Vessels in Venous Pathway After Extracardiac Total Cavopulmonary Connection

The Somatic Growth of Autologous Vessels in Venous Pathway After Extracardiac Total Cavopulmonary Connection

Tratamento convencional e endovascular para rara associação de doenças: síndrome de veia cava superior e aneurisma aorto-ilíaco - controle após 12 meses

Salvage resection of advanced mediastinal tumors

Contact Info

Product

Resources

About